Trends in disparities in receipt of adjuvant therapy for elderly stage III colon cancer patients: the role of the medical oncologist evaluation.

Trends in disparities in receipt of adjuvant therapy for elderly stage III colon cancer patients: the role of the medical oncologist evaluation.

Item
http://www.wikidata.org/entity/Q43270000
Factors influencing treatment selection and survival in advanced lung cancerCost-effectiveness of second-line chemotherapy/biologics among elderly metastatic colon cancer patientsAdherence to clinical practice guidelines for adjuvant chemotherapy for colorectal cancer in a Canadian province: a population-based analysisChemotherapy in Patients Older than or Equal to 75 Years with Advanced Non-small Cell Lung CancerRace and Insurance Differences in the Receipt of Adjuvant Chemotherapy Among Patients With Stage III Colon Cancer.Age Nutrition Chirugie (ANC) study: impact of a geriatric intervention on the screening and management of undernutrition in elderly patients operated on for colon cancer, a stepped wedge controlled trial.How do surgeons decide to refer patients for adjuvant cancer treatment? Protocol for a qualitative studyAssociation between the availability of medical oncologists and initiation of chemotherapy for patients with stage III colon cancer.A novel approach to improve health status measurement in observational claims-based studies of cancer treatment and outcomes.Examining potential colorectal cancer care disparities in the Veterans Affairs health care system.Does the type of first-line regimens influence the receipt of second-line chemotherapy treatment? An analysis of 3211 metastatic colon cancer patients.The effect of health insurance status on the treatment and outcomes of patients with colorectal cancer.Patterns of Referral for Adjuvant Chemotherapy for Stage II and III Colon Cancer: A Population-Based Study.Comparative and cost-effectiveness of oxaliplatin-based or irinotecan-based regimens compared with 5-fluorouracil/leucovorin alone among US elderly stage IV colon cancer patients.Use of and spending on supportive care medications among Medicare beneficiaries with cancer.Is chemotherapy in elderly patients with metastatic or recurrent gastric cancer as tolerable and effective as in younger patients?
P2860

Trends in disparities in receipt of adjuvant therapy for elderly stage III colon cancer patients: the role of the medical oncologist evaluation.

Item
http://www.wikidata.org/entity/Q43270000
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Trends in disparities in recei ...... medical oncologist evaluation.
@en
Trends in disparities in recei ...... medical oncologist evaluation.
@nl
type
label
Trends in disparities in recei ...... medical oncologist evaluation.
@en
Trends in disparities in recei ...... medical oncologist evaluation.
@nl
prefLabel
Trends in disparities in recei ...... medical oncologist evaluation.
@en
Trends in disparities in recei ...... medical oncologist evaluation.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Trends in disparities in recei ...... medical oncologist evaluation
@en
P2093
P304
P31
P356
10.1097/MLR.0B013E3181B58A85
P433
P478
P50
P577
P698